Pediatric drugs pharmacokinetics;Farmacocinética de medicamentos de uso pediátrico, visión actual

Revista Chilena de Pediatria

Volumn 79, Issue 3, 2008, Pages 249-258

  Saavedra S , Iván ^a   Quiñones S , Luis ^a   Saavedra B , Mónica ^a   Sasso A , Jaime ^a   León T , Jorge ^a   Roco A , Angela ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Bioavailability; Pediatric drugs; Pharmacokinetics

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CARBAMAZEPINE; CEFALOTIN; CEFOTAXIME; CHLORAMPHENICOL; CISAPRIDE; CLOXACILLIN; DIAZEPAM; DIGOXIN; DRUG; FUROSEMIDE; GENTAMICIN; INDOMETACIN; KETOPROFEN; LORATADINE; NAFCILLIN; OMEPRAZOLE; PARACETAMOL; PHENOBARBITAL; PHENYTOIN; PROPRANOLOL; THEOPHYLLINE; TOBRAMYCIN; TOPIRAMATE; VALPROIC ACID; WARFARIN; ZIDOVUDINE;

CHILD; CLINICAL PHARMACOLOGY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG TRANSFORMATION; ENZYME ACTIVITY; GASTROINTESTINAL TRACT FUNCTION; HUMAN; INTESTINE FLORA; KIDNEY FUNCTION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BIFIDUS; LIPID SOLUBILITY; PEDIATRIC PHARMACOLOGY; REVIEW; STOMACH PH;

EID: 50449101255     PISSN: 03704106     EISSN: 07176228     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. a edición, McGraw hill interamericana, Madrid, 2004.
2. Avery: Neonatología, 3a. Edición, ed. Panamericana, Canadá, 1990.
3. Heusser F, Garay F: Fármacos de uso pediátrico, QT prolongado y trastornos del ritmo cardíaco. Rev Chil Pediatr 1999; 70 (6): 457-63.
4. Crom WR: Pharmacokinetcis in child. Environ Health Perspect 1994; 102 (supl 11): 111-18.
5. Bartelink IK, Rademaker CMA, Schobben AFAM, Van Den Ander JN: Guidelines on pediatric dosing on the basis of developmental physiology and pharmacokinetic considerations. Clin Pharmacokinet 2006; 45 (11): 1077-97.
6. Goodman & Gilman: Laurence Brunton, undécima edición, McGraw-Hill Interamericana, México, DF, 2006.
7. Strolin Benedetti M, Baltes EL: Drug metabolism and disposition in children. Fundam Clin Pharmacol 2003; 17: 281-99.
8. Kearns GL: Impact of developmental pharmacology on pediatric study desing; overcoming the challenges. J Allergy Clin Immunol 2000; 106: s128-39.
9. Malgor LA, Valsecia ME: Farmacología médica, volumen 4, cap. 4: farmacocinética y farmacodinamia en pediatría, 2000. Base de datos: cátedra farmacología, Facultad de Medicina, Universidad Nacional del Nordeste, República Argentina.
10. Ogutu BR, Newton CR, Crawley J, et al: Pharmacokinetics and anticonvulsant effects of diazepam in children with severe falciparum malaria and convulsions. Br J Clin Pharmacol 2002; 53 (1): 49-57.
11. Albani M, Wernicke I: Oral phenytoin in infancy: dose requirement, absorption, and elimination. Pediatr Pharmacol (New York) 1983; 3 (3-4): 229-36.
12. Mislap RL, Hill MR, Szefler SJ: Special pharmacokinetic considerations in children: in applied pharmacokinetics: principles of therapeutic drug monitoring, 3er. Ed. Vancouver Whasington: applied therapeutics, 1992; 10.1-10-32
13. Matsubara T, Yamada N, Mitomi T, et al: Cytochrome p-450-dependent monooxygenase activities in prenatal and postnatal human livers: comparison of human liver 7-alkoxycoumarin o-dealkylases with rat liver enzymes. Jpn J Pharmacol 1986; 40 (3): 389-98.
14. Kearns GL, Robinson PK, Wilson JT, et al: Cisapride disposition in neonates and infants: in vivo reflection of cytochrome p450 3a4 ontogeny. Clin Pharmacol Ther 2003; 74: 312-25.
15. Cenimef centro nacional de información de medicamentos y farmacovigilancia. Instituto de Salud Pública de Ce, www.ispch.cl resolución exenta no 2586, 2002, resol.ución exenta no 3668, 2002, resolución exenta no 4392, 2001.
16. Kokki H, Karvinen M, Suhonen P: Pharmacokinetics of intravenous and rectal ketoprofen in young children. Clin Pharmacokinet 2003; 42: 373-9.
17. Kearns GL, Andersson T, James LP, et al: Omeprazole disposition in children following single-dose administration. J Clin Pharmacol 2003; 43: 840-8.
18. Salmun LM, Herron JM, Banfield C, Padhi D, Lorber R, Affrime MB: The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years. Clin Ther 2000; 22 (5): 613-21.
19. Schaad UB, Casey PA, Cooper DL: Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Antimicrob Agents Chemother 1983; 23 (2): 252-5.
20. Capparelli EV, Englund JA, Connor JD, et al: Population pharmacokinetics and pharmacodynamics of zidovudine in hiv-infected infants and children. J Clin Pharmacol 2003; 43: 133-40.
21. Kearns GL, Abdel-Rahman SM, Alander, et al: Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 2003; 349: 1157-67.
22. Bannwarth B, Péhourcq F: Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues. Drugs 2003; 63 (2): 5-13.
23. Anderson BJ, Woollard GA, Holford NH: A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children. Br J Clin Pharmacol 2000; 50 (2): 125-34.